5242802025-10-012025-12-315242802025-04-012025-12-315242802025-10-012025-12-31in-capmkt:OtherExpenses1Member5242802025-10-012025-12-31in-capmkt:OtherExpenses2Member5242802025-04-012025-12-31in-capmkt:OtherExpenses1Member5242802025-04-012025-12-31in-capmkt:OtherExpenses2Member5242802025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15242802025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15242802025-10-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15242802025-04-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15242802025-10-012025-12-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares524280KOPRANNOTLISTEDINE082A01010KOPRAN LIMITEDMain BoardEquity2025-04-012026-03-312026-01-222026-01-13INRLakhsQuarterlyThird quarterSingle segmentPharmaceuticals2026-01-2212:15:002026-01-2214:50:00Declaration of unmodified opinion2025-10-012025-12-31UnauditedConsolidated1942798000679000194347700011786510001229800011960500016567300026694000441610002889500001836032000107445000010744500032528000-1847900014049000093396000000093396000-188900091507000933960000915070000482856000101.931.93001.931.93Notes:- <BR> 1) The above Statement of consolidated and standalone unaudited financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act 2013, read with Companies (lndian Accounting Standards) Rules, 2015, as amended and other accounting principles generally accepted in lndia. There is no minority interest. <BR> 2) The above Statement of consolidated and standalone unaudited financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on January 22, 2026 and have been reviewed by the Statutory Auditors of the Company who have expressed unmodified opinion. <BR> 3) The Company and the subsidiaries together referred to as "Group" are engaged primarily in the pharmaceuticals business and there are no separate reportable segments as per Ind AS 108 on " Operating Segment Reporting". <BR> <BR> 4) The Government of India, vide notification dated November 21, 2025, has notified the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020, and the Occupational Safety, Health and Working Conditions Code, 2020 (collectively referred to as the “New Labour Codes”), which consolidate and replace twenty-nine existing central labour laws into unified framework governing employee benefits during employment and post-employment. The New Labour codes, amongst other things introduced changes, including a uniform definition of wages for statutory purposes. Once Central / State Rules are notified by the Government on all aspects of the Codes, the management of the company will evaluate its impact, on the employee benefits and provide for the same in the books of accounts, if necessary <BR> 5) Figures for the previous period have been regrouped or reclassified, wherever necessary to make them comparable with the figures of the current period. <BR> 2025-04-012025-12-31UnauditedConsolidated447405300025530004476606000291252300018987000-68020004875740007300700012956900077167500043865330009007300009007300032528000-1111200021416000068657000000068657000-528700063370000686570000633700000482856000101.421.42001.421.42other expenses264228000Foreign Exchange Loss(Net)24722000other expenses688493000Foreign Exchange Loss(Net)83182000Remeasurement of defined benefit plans-2904000-2904000Remeasurement of defined benefit plans-8710000-8710000-730000-2191000Exchange difference in translating the financial statement of foreign operation285000285000Exchange difference in translating the financial statement of foreign operation1232000123200000-1889000-5287000UnauditedtrueKhandelwal Jain & Cotrue2028-08-31